Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis

计划入组 120 人 · 首次发布于 2022 年 9 月 14 日

A Multinational Phase III Study of CS-8958 (MARVEL)

计划入组 1,002 人 · 首次发布于 2008 年 12 月 5 日

The Sublimated Mare Milk Supplement in Hepatitis C

计划入组 100 人 · 首次发布于 2018 年 9 月 13 日

Non-Hallucinogenic Neuroplasticity Program (Marvel Biotechnology)

Mesenchymal stem cell secretome(Universitas Sebelas Maret)

UNIVERSITAS SEBELAS MARET

Indonesia

RODRIGO MARCEL VALENTIM DA SILVA

Brazil

MARVEL HEALTH (AUSTRALIA) PTY. LTD.

Australia

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech Reports Record First Half 2025 Results with Over 200% Product Revenue Growth

Seres Therapeutics Appoints Co-CEOs as Company Seeks Partnerships for SER-155 Development